Keyphrases
Lung Cancer
100%
T Cells
45%
Foreign Element
27%
Chemotherapy
18%
Small Cell Lung Cancer
18%
Cancer Cells
18%
Clinical Trials
18%
Immune Cells
18%
Cancer Center
18%
Non-small Cell Lung Cancer (NSCLC)
18%
Immune System
18%
Phase II Study
18%
Cancer Mortality
18%
Military Service Members
18%
Cancer Growth
9%
Kill Switch
9%
Common Strategies
9%
Small Cell
9%
Resistance Mechanisms
9%
Cancer Causes
9%
United States
9%
Recent Advances
9%
Left behind
9%
Targeted Therapy
9%
Immune Alterations
9%
Foreign Material
9%
Cancer-specific Survival
9%
Healthcare Quality Improvement
9%
Laboratory Animals
9%
Regulatory Submission
9%
Unique Properties
9%
Human Cancer
9%
Genetic Engineering
9%
Success Probability
9%
Biologic Activity
9%
Smoking Prevalence
9%
Interleukin-15 (IL-15)
9%
Non-smoking
9%
Evade
9%
Cancer Control
9%
Grant Applications
9%
Lymphoma
9%
Virus
9%
Chemotherapy Alone
9%
Human Patients
9%
Large Scale Trial
9%
Medicine and Dentistry
Lung Cancer
100%
T Cell
45%
Immunotherapy
36%
Chimeric Antigen Receptor T-Cell Therapy
36%
Malignant Neoplasm
36%
Non Small Cell Lung Cancer
18%
Small Cell Lung Cancer
18%
Immunocompetent Cell
18%
Cancer Mortality
18%
Immune System
18%
Clinical Trial
18%
Cancer Cell
18%
Targeted Therapy
9%
Cancer Control
9%
Cancer Growth
9%
Foreign Body
9%
Interleukin 15
9%
Side Effect
9%
Pharmacology, Toxicology and Pharmaceutical Science
Lung Cancer
100%
Malignant Neoplasm
54%
Immunotherapy
36%
Clinical Trial
18%
Cancer Mortality
18%
Small Cell Lung Cancer
18%
Chemotherapy
18%
Non Small Cell Lung Cancer
18%
Side Effect
9%
Experimental Animal
9%
Foreign Body
9%
Cancer Growth
9%
Cancer Chemotherapy
9%
Interleukin 15
9%